{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:40:17Z","timestamp":1758937217869,"version":"3.44.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.leukres.2013.01.014","type":"journal-article","created":{"date-parts":[[2013,2,12]],"date-time":"2013-02-12T18:30:54Z","timestamp":1360693854000},"page":"520-530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Aberrant activation of ROS1 represents a new molecular defect in chronic myelomonocytic leukemia"],"prefix":"10.1016","volume":"37","author":[{"given":"Daniela","family":"Cilloni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Carturan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Bracco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Campia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Rosso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Torti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Gaidano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pimjai","family":"Niparuck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Favole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Signorino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Iacobucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Morano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pellegrino","family":"Musto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Frassoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Saglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2013.01.014_bib0005","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1056\/NEJMra044389","article-title":"Tyrosine kinases as targets for cancer therapy","volume":"353","author":"Krause","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2013.01.014_bib0010","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000101707","article-title":"Chronic myeloproliferative disorders: the role of tyrosine kinases in pathogenesis, diagnosis and therapy","volume":"74","author":"Macdonald","year":"2007","journal-title":"Pathobiology"},{"key":"10.1016\/j.leukres.2013.01.014_bib0015","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000140631","article-title":"Fibroblast growth factor receptor and platelet-derived growth factor receptor abnormalities in eosinophilic myeloproliferative disorders","volume":"119","author":"Cross","year":"2008","journal-title":"Acta Haematol"},{"key":"10.1016\/j.leukres.2013.01.014_bib0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2141.2007.06628.x","article-title":"Two novel imatinib-responsive PDGFRA fusion genes in chronic eosinophilic leukaemia","volume":"138","author":"Curtis","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2013.01.014_bib0025","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.1365-2141.2003.04051.x","article-title":"Novel translocations that disrupt the platelet-derived growth factor receptor beta (PDGFRB) gene in BCR-ABL-negative chronic myeloproliferative disorders","volume":"120","author":"Baxter","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2013.01.014_bib0030","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature09999","article-title":"A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia","volume":"473","author":"Klinakis","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2013.01.014_bib0035","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1200\/JCO.2009.27.1361","article-title":"Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1","volume":"28","author":"Kohlmann","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2013.01.014_bib0040","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature10496","article-title":"Frequent pathway mutations of splicing machinery in myelodysplasia","volume":"78","author":"Yoshida","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2013.01.014_bib0045","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1182\/blood-2012-01-404863","article-title":"SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)","volume":"120","author":"Meggendorfer","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.01.014_bib0050","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1097-2765(03)00274-0","article-title":"Autoinhibition of Bcr-Abl through its SH3 domain","volume":"12","author":"Smith","year":"2003","journal-title":"Mol Cell"},{"key":"10.1016\/j.leukres.2013.01.014_bib0055","first-page":"1911","article-title":"Internal tandem duplication of the flt3 gene found in acute myeloid leukemia","volume":"10","author":"Nakao","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2013.01.014_bib0060","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1056\/NEJM198811103191902","article-title":"Neu-protein overexpression in breast cancer, association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer","volume":"319","author":"van de Vijver","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2013.01.014_bib0065","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1365-2141.2004.05107.x","article-title":"Suppressor of cytokine signalling-1 gene silencing in acute myeloid leukaemia and human haematopoietic cell lines","volume":"126","author":"Watanabe","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2013.01.014_bib0070","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000131937","article-title":"Chromosome 6","volume":"36","author":"Mitelman","year":"1983","journal-title":"Cytogenet Cell Genet"},{"key":"10.1016\/j.leukres.2013.01.014_bib0075","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0165-4608(83)90039-0","article-title":"Chromosome 6q involvement in human malignant melanoma","volume":"9","author":"Trent","year":"1983","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.leukres.2013.01.014_bib0080","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0165-4608(81)90095-9","article-title":"Specific chromosome change in ovarian cancer","volume":"3","author":"Atkin","year":"1981","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.leukres.2013.01.014_bib0085","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nm.2658","article-title":"RET, ROS1 and ALK fusions in lung cancer","volume":"18","author":"Takeuchi","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.leukres.2013.01.014_bib0090","first-page":"3000","article-title":"Human, c-ROS gene homologous to the v-ROS sequence of UR2 sarcoma virus encodes for a transmembrane receptor-like molecule","volume":"6","author":"Matsushime","year":"1988","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.leukres.2013.01.014_bib0095","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1128\/jvi.40.1.268-275.1981","article-title":"Some biological properties of two new avian sarcoma viruses","volume":"40","author":"Balduzzi","year":"1981","journal-title":"J Virol"},{"key":"10.1016\/j.leukres.2013.01.014_bib0100","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1128\/jvi.42.1.143-152.1982","article-title":"Cellular sequences related to three new onc genes of avian sarcoma virus (fps, yes, and ROS) and their expression in normal and transformed cells","volume":"42","author":"Shibuya","year":"1982","journal-title":"J Virol"},{"key":"10.1016\/j.leukres.2013.01.014_bib0105","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1128\/jvi.41.3.833-841.1982","article-title":"Genetic structure and transforming sequence of avian sarcoma virus UR2","volume":"41","author":"Wang","year":"1982","journal-title":"J Virol"},{"key":"10.1016\/j.leukres.2013.01.014_bib0110","doi-asserted-by":"crossref","first-page":"6568","DOI":"10.1073\/pnas.83.17.6568","article-title":"The humanc-ros gene (ROS) is located at chromosome region 6q16\u20136q22","volume":"83","author":"Nagarajan","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.leukres.2013.01.014_bib0115","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1128\/jvi.42.1.228-236.1982","article-title":"Avian sarcoma virus UR2 encodes a transforming protein which is associated with a unique protein kinase activity","volume":"42","author":"Feldman","year":"1982","journal-title":"J Virol"},{"key":"10.1016\/j.leukres.2013.01.014_bib0120","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/307521a0","article-title":"Close similarity of epidermal growth factor receptor and v-erbB on oncogene protein sequences","volume":"307","author":"Downward","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2013.01.014_bib0125","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/0092-8674(85)90334-4","article-title":"The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling","volume":"40","author":"Ebina","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2013.01.014_bib0130","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0092-8674(85)80047-7","article-title":"The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1","volume":"41","author":"Sherr","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2013.01.014_bib0135","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1128\/jvi.64.5.2117-2125.1990","article-title":"Tissue-specific expression of rat c-ROS-1 gene and partial structural similarity of its predicted products with sev protein of Drosophila melanogaster","volume":"64","author":"Matsushime","year":"1990","journal-title":"J Virol"},{"key":"10.1016\/j.leukres.2013.01.014_bib0140","first-page":"37","article-title":"The multifaceted roles of the receptor tyrosine kinase ROS in development and cancer","volume":"1795","author":"Acquaviva","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.leukres.2013.01.014_bib0145","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1227\/00006123-199102000-00007","article-title":"Expression of platelet-derived growth factors, transforming growth factors, and the ROS gene in a variety of primary human brain tumors","volume":"28","author":"Mapstone","year":"1991","journal-title":"Neurosurgery"},{"key":"10.1016\/j.leukres.2013.01.014_bib0150","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0165-4608(94)90128-7","article-title":"Analysis of onocogen expression in primary human gliomas: evidence for increased expression of the ROS onocogene","volume":"72","author":"Watkins","year":"1994","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.leukres.2013.01.014_bib0155","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1073\/pnas.242741799","article-title":"Oncogenic targeting of an activated tyrosine kinase to the Golgi apparatus in aglioblastoma","volume":"100","author":"Charest","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.leukres.2013.01.014_bib0160","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1073\/pnas.87.12.4799","article-title":"Characterization of ROS1 cDNA from a human glioblastoma cell line","volume":"87","author":"Birchmeier","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.leukres.2013.01.014_bib0165","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0092-8674(88)90193-6","article-title":"Control of photoreceptor cell fate by the sevenless protein requires a functional tyrosine kinase domain","volume":"54","author":"Basler","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2013.01.014_bib0170","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1101\/gad.2.6.620","article-title":"Nucleotide sequence and structure of the sevenless gene of Drosophila melanogaster","volume":"2","author":"Bowtell","year":"1988","journal-title":"Genes Dev"},{"key":"10.1016\/j.leukres.2013.01.014_bib0175","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/leu.2010.257","article-title":"Inhibition of Grb2 expression demonstrates an important role in BCR-ABL-mediated MAPK activation and transformation of primary human hematopoietic cells","volume":"25","author":"Modi","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2013.01.014_bib0185","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/sj.leu.2403998","article-title":"The NF-kappaB pathway blockade by the IKK inhibitor PS1145 can overcome imatinib resistance","volume":"1","author":"Cilloni","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2013.01.014_bib0190","doi-asserted-by":"crossref","first-page":"11107","DOI":"10.1074\/jbc.M108166200","article-title":"The role of phosphatidylinositol 3-kinase, rho family GTPases, and STAT3 in Ros-induced cell transformation","volume":"277","author":"Nguyen","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.leukres.2013.01.014_bib0180","series-title":"World Health Organization classification of tumours of haematopoietic and lymphoid tissues","first-page":"76","article-title":"Chronic myelomonocytic leukaemia","author":"Orazi","year":"2008"},{"key":"10.1016\/j.leukres.2013.01.014_bib0195","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.01.014_bib0200","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3324\/haematol.2010.030957","article-title":"Cytogenetic risk stratification in chronic myelomonocytic leukemia","volume":"96","author":"Such","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2013.01.014_bib0205","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1158\/0008-5472.CAN-08-3351","article-title":"Epigenetic regulation of c-ROS receptor tyrosine kinase expression in malignant gliomas","volume":"69","author":"Jun","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2013.01.014_bib0210","doi-asserted-by":"crossref","first-page":"6793","DOI":"10.1093\/emboj\/20.23.6793","article-title":"Tyrosine phosphorylation of Grb2 by Bcr\/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling","volume":"20","author":"Li","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.leukres.2013.01.014_bib0215","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1182\/blood.V98.6.1773","article-title":"Chronic myelogenous leukemia blast cell proliferation is inhibited by peptides that disrupt Grb2\u2013SoS complexes","volume":"98","author":"Kardinal","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.01.014_bib0220","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1126\/science.2406902","article-title":"Induction of chronic myelogenous leukemia in mice by the P210bcr\/abl gene of the Philadelphia chromosome","volume":"247","author":"Daley","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.leukres.2013.01.014_bib0225","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.hoc.2004.03.008","article-title":"Biology of chronic myelogenous leukemia signaling pathways of initiation and transformation","volume":"18","author":"Melo","year":"2004","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.leukres.2013.01.014_bib0230","doi-asserted-by":"crossref","first-page":"5622","DOI":"10.1016\/j.bmcl.2009.08.029","article-title":"Design, synthesis, screening, and molecular modeling study of a new series of ROS1 receptor tyrosine kinase inhibitors","volume":"19","author":"El-Deeb","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.leukres.2013.01.014_bib0235","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1016\/j.bmcl.2009.06.066","article-title":"Design, synthesis and biological evaluation of new potent and highly selective ROS1-tyrosine kinase inhibitor","volume":"19","author":"Park","year":"2009","journal-title":"Bioorg Med Chem Lett"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212613000301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212613000301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:58:03Z","timestamp":1758934683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212613000301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0145212613000301"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2013.01.014","relation":{},"ISSN":["0145-2126"],"issn-type":[{"type":"print","value":"0145-2126"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aberrant activation of ROS1 represents a new molecular defect in chronic myelomonocytic leukemia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2013.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}